Viewing Study NCT04727151

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 11:40 PM
Ignite Modification Date: 2026-06-02 @ 6:43 AM
Study NCT ID: NCT04727151
Status: TERMINATED
Last Update Posted: 2025-06-08
First Post: 2021-01-20
Is NOT Gene Therapy: True
Has Adverse Events: True
Brief Title: TAC T-cells for the Treatment of HER2-positive Solid Tumors
Sponsor: Triumvira Immunologics, Inc.
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None HER2 Positive Gastric Cancer View
None Metastatic HER2 Positive Gastroesophageal Junction Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None HER2 Positive Gastric Cancer View
None HER2 Positive gastroesophageal adenocarcinoma View